Abbott ABT Medical Devices — Depreciation

Other segment segments

Similar metrics at other companies

IR

IRMedical — D&A

$5.63M-4.3%

NDSNMedical Fluid Systems — Depreciation, Depletion and Amortization

$3.01M-6.6%

NDSNMedical and Fluid Solutions — Depreciation

$7.83M-9.7%

MDTOther Operating Segments, Including Diabetes — Depreciation expense

$31.75M+12.4%

FTVAdvanced Healthcare Solutions — Depreciation, Depletion and Amortization

$50.8M+2.6%

CHDConsumer Domestic — D&A

$53.9M+5.1%

Questions, answered.

What is Abbott's medical devices — depreciation?

Abbott (ABT) reported medical devices — depreciation of $100M in Q1 2026.

How has Abbott's medical devices — depreciation changed year-over-year?

Abbott's medical devices — depreciation increased by 13.6% year-over-year, from $88M to $100M.

What is the long-term trend for Abbott's medical devices — depreciation?

Over 4 years (2021 to 2025), Abbott's medical devices — depreciation has grown at a 7.3% compound annual growth rate (CAGR), from $285M to $378M.

What does medical devices — depreciation mean?

The non-cash expense representing the wear and tear of physical assets over time.

How do you interpret medical devices — depreciation?

Changes reflect the scale of the capital asset base and the age of the manufacturing infrastructure.

How does medical devices — depreciation compare across companies?

Standard accounting metric for capital-intensive manufacturing businesses.